# A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

> **NCT00118716** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 248 (actual)

## Conditions studied

- Bronchospasm
- Activity/Exercise Induced Bronchospasm

## Interventions

- **DRUG:** Fluticasone propionate/salmeterol
- **DRUG:** Fluticasone Propionate

## Key facts

- **NCT ID:** NCT00118716
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12-23
- **Primary completion:** 2006-04-01
- **Final completion:** 2006-04-23
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2019-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00118716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00118716, "A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00118716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*